Clinical and biological implications of the tumor microenvironment

Cancer Microenvironment

Volumn 5, Issue 2, 2012, Pages 95-112

  Tarin, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer diagnosis; Cancer treatment; Carcinoma in situ; Cell interactions; Embryonic development; EMT. Dysplasia; Epithelial stromal interactions; Histopathology; Inappropriate gene expression; Inflammation; Metastasis; Tissue interactions

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER THERAPY; CARCINOGENESIS; CELL ACTIVITY; CELL FUNCTION; CELL INTERACTION; CELL INVASION; CELL MICROENVIRONMENT; CELL MIGRATION; CELL STRUCTURE; DEGENERATION; DEVELOPMENT; FEEDBACK SYSTEM; HOST CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MICROCOSM; MICROENVIRONMENT; MOLECULAR INTERACTION; MOUSE; NONHUMAN; ORGAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR REGRESSION;

EID: 85027929066     PISSN: 18752292     EISSN: 18752284     Source Type: Journal    
DOI: 10.1007/s12307-012-0099-6     Document Type: Article

References (80)

1. Orr J (1938) Changes antecedent to tumour formation during the treatment of mouse skin with carcinogenic hydrocarbons. J Pathol Bacteriol 46:495-515
2. Tarin D (1972) Morphological studies on the mechanism of carcinogenesis. In: Tarin D (ed) Tissue interactions in carcinogenesis. Academic, London, pp 227-289
3. Tarin D (1972) Tissue interactions in morphogenesis, morphostasis and carcinogenesis. J Theor Biol 34(1):61-72
4. Kratochwil K (1972) Tissue interaction during embryonic development. In: Tarin D (ed) Tissue interactions in carcinogenesis. Academic, London, pp 1-47
5. Tarin D (1967) Sequential electron microscopical study of experimental mouse skin carcinogenesis. Int J Cancer 2(3):195-211
6. Tarin D (1969) Fine structure of murine mammary tumours: the relationship between epithelium and connective tissue in neoplasms induced by various agents. Br J Cancer 23(2):417-425
7. Billingham RE, Orr JW, Woodhouse DL (1951) Transplantation of skin components during chemical carcinogenesis with 20- methylcholanthrene. Br J Cancer 5(4):417-432
8. Orr J, Spencer A (1972) Transplantation studies of the role of the stroma in epidermal carcinogenesis. In: Tarin D (ed) Tissue Interactions in carcinogenesis. Academic, London, pp 291-303
9. Brand KG, Buoen LC, Johnson KH, Brand I (1975) Etiological factors, stages, and the role of the foreign body in foreign body tumorigenesis: a review. Cancer Res 35(2):279-286
10. Tarin D (1972) Tissue interactions in carcinogenesis. Academic, London
11. Folkman J (2006) Angiogenesis. Annu Rev Med 57:1-18
12. Tarin D (2011) Cell and tissue interactions in carcinogenesis and metastasis and their clinical significance. Semin Cancer Biol 21 (2):72-82
13. Tarin D (2011) Inappropriate gene expression in human cancer and its far-reaching biological and clinical significance. Cancer Metastasis Rev
14. Spemann H (1938) Embryonic induction and development. In. Yale University Press, New Haven
15. Tarin D (1972) Tissue interactions and the maintenance of histological structure in adults. In: Tarin D (ed) Tissue interactions in carcinogenesis. Academic, London, pp 81-93
16. Warburton D, Wuenschell C, Flores-Delgado G, Anderson K (1998) Commitment and differentiation of lung cell lineages. Biochem Cell Biol 76(6):971-995
17. Beers MF, Morrisey EE (2011) The three R's of lung health and disease: repair, remodeling, and regeneration. J Clin Invest 121 (6):2065-2073
18. Saxén L (1972) Interactive mechanisms in morphogenesis. In: Tarin D (ed) Tissue interactions in carcinogenesis. Academic, London, pp 49-80
19. Nagatomo T, Ohga S, Takada H et al (2004) Microarray analysis of human milk cells: persistent high expression of osteopontin during the lactation period. Clin Exp Immunol 138(1):47-53
20. Nemir M, Bhattacharyya D, Li X, Singh K, Mukherjee AB, Mukherjee BB (2000) Targeted inhibition of osteopontin expression in the mammary gland causes abnormal morphogenesis and lactation deficiency. J Biol Chem 275(2):969-976
21. Kyriakides TR, Bornstein P (2003) Matricellular proteins as modulators of wound healing and the foreign body response. Thromb Haemost 90(6):986-992
22. Ehrchen J, Heuer H, Sigmund R, Schafer MK, Bauer K (2001) Expression and regulation of osteopontin and connective tissue growth factor transcripts in rat anterior pituitary. J Endocrinol 169(1):87-96
23. Tarin D, Matsumura Y (1993) Deranged activity of the CD44 gene and other loci as biomarkers for progression to metastatic malignancy. J Cell Biochem Suppl 17G:173-185
24. Weis SM, Cheresh DA (2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 17(11):1359-1370
25. Bornstein P, Sage EH (2002) Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 14(5):608-616
26. Goodison S, Tarin D (1998) Clinical implications of anomalous CD44 gene expression in neoplasia. Front Biosci 3:e89-e109
27. Suzuki M, Mose E, Galloy C, Tarin D (2007) Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts. Am J Pathol 171(2):682-692
28. Lim PK, Bliss SA, Patel SA et al (2011) Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res 71 (5):1550-1560
29. Musumeci M, Coppola V, Addario A et al (2011) Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene 30(41):4231-4242
30. Sugino T, Gorham H, Yoshida K et al (1996) Progressive loss of CD44 gene expression in invasive bladder cancer. Am J Pathol 149 (3):873-882
31. Barnhill RL (2006) The Spitzoid lesion: rethinking Spitz tumors, atypical variants, 'Spitzoid melanoma' and risk assessment. Mod Pathol 19(Suppl 2):S21-S33
32. Esserman L, Shieh Y, Thompson I (2009) Rethinking screening for breast cancer and prostate cancer. JAMA 302(15):1685-1692
33. Sanders ME, Schuyler PA, Dupont WD, Page DL (2005) The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of longterm follow-up. Cancer 103(12):2481-2484
34. Nickerson HJ, Matthay KK, Seeger RC et al (2000) Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. J Clin Oncol 18(3):477-486
35. Price JE, Carr D, Jones LD, Messer P, Tarin D (1982) Experimental analysis of factors affecting metastatic spread using naturally occurring tumours. Invasion Metastasis 2(2):77-112
36. Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet i:571-573
37. Tarin D, Price JE, Kettlewell MG, Souter RG, Vass AC, Crossley B (1984) Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res 44(8):3584-3592
38. Tarin D, Price JE (1981) Influence of microenvironment and vascular anatomy on "metastatic" colonization potential of mammary tumors. Cancer Res 41(9 Pt 1):3604-3609
39. Hart IR, Fidler IJ (1980) Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res 40 (7):2281-2287
40. Suzuki M, Mose ES, Montel V, Tarin D (2006) Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency. Am J Pathol 169(2):673-681
41. Goodison S, Kawai K, Hihara J et al (2003) Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. Clin Cancer Res 9(10 Pt 1):3808-3814
42. Tarin D (1976) Cellular interactions in neoplasia. In: Weiss L (ed) Fundamental aspects of metastasis. North Holland Publishing Co, Amsterdam, pp 151-187
43. Yasunaga M, Manabe S, Tarin D, Matsumura Y (2011) Cancerstroma targeting therapy by cytotoxic immunoconjugate bound to the collagen 4 network in the tumor tissue. Bioconjug Chem 22 (9):1776-1783
44. Horak E, Darling DL, Tarin D (1986) Analysis of organ-specific effects on metastatic tumor formation by studies in vitro. J Natl Cancer Inst 76(5):913-922
45. Nicolson GL, Dulski KM (1986) Organ specificity of metastatic tumor colonization is related to organ-selective growth properties of malignant cells. Int J Cancer 38(2):289-294
46. Attwood HD, Park WW (1961) Embolism to the lungs by trophoblast. J Obstet Gynaecol Br Commonw 68:611-617
47. Carstens PH (1969) Pulmonary bone marrow embolism following external cardiac massage. Acta Pathol Microbiol Scand 76(4):510-514
48. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883-899
49. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860-867
50. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646-674
51. Ekbom A, Helmick C, Zack M, Adami HO (1990) Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323(18):1228-1233
52. Kudo Y, Kamisawa T, Anjiki H, Takuma K, Egawa N (2011) Incidence of and risk factors for developing pancreatic cancer in patients with chronic pancreatitis. Hepatogastroenterology 58 (106):609-611
53. Reid BJ, Weinstein WM (1987) Barrett's esophagus and adenocarcinoma. Annu Rev Med 38:477-492
54. Balkwill F, Charles KA, Mantovani A (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7(3):211-217
55. Mahmoud SM, Lee AH, Paish EC, Macmillan RD, Ellis IO, Green AR (2011) Tumour-infiltrating macrophages and clinical outcome in breast cancer. J Clin Pathol
56. Wyckoff JB, Wang Y, Lin EY et al (2007) Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 67(6):2649-2656
57. Nash JR, Price JE, Tarin D (1981) Macrophage content and colony-forming potential in mouse mammary carcinomas. Br J Cancer 43(4):478-485
58. Shree T, Olson OC, Elie BT et al (2011) Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. Genes Dev 25(23):2465-2479
59. Theoharides TC, Conti P (2004) Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 25(5):235-241
60. Mahmoud SM, Paish EC, Powe DG et al (2011) Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 29(15):1949-1955
61. Mahmoud SM, Lee AH, Paish EC, Macmillan RD, Ellis IO, Green AR (2011) The prognostic significance of B lymphocytes in invasive carcinoma of the breast. Breast Cancer Res Treat
62. Mahmoud SM, Paish EC, Powe DG et al (2011) An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer. Breast Cancer Res Treat 127(1):99-108
63. Talmadge JE (2011) Immune cell infiltration of primary and metastatic lesions: mechanisms and clinical impact. Semin Cancer Biol 21(2):131-138
64. Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2(6):442-454
65. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelialmesenchymal transitions in development and disease. Cell 139 (5):871-890
66. Hugo H, Ackland ML, Blick T et al (2007) Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 213(2):374-383
67. Tarin D, Thompson EW, Newgreen DF (2005) The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 65 (14):5996-6000, discussion -1
68. Tarin D (2011) Inappropriate gene expression in cancer and its far reaching clinical and biological significance. Canc Metastasis Rev
69. Domagala W, Wozniak L, Lasota J, Weber K, Osborn M (1990) Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas. Am J Pathol 137 (5):1059-1064
70. Kubiak RS, Szadowska A (1997) Invasive lobular carcinoma of the breast: correlations between morphological features, vimentin expression, oestrogen receptor status and prognosis. Breast 6:89-96
71. Domagala W, Markiewski M, Kubiak R, Bartkowiak J, Osborn M (1993) Immunohistochemical profile of invasive lobular carcinoma of the breast: predominantly vimentin and p53 protein negative, cathepsin D and oestrogen receptor positive. Virchows Arch A Pathol Anat Histopathol 423(6):497-502
72. Slack NH, Bross ID (1975) The influence of site of metastasis on tumour growth and response to chemotherapy. Br J Cancer 32 (1):78-86
73. Fidler IJ, Wilmanns C, Staroselsky A, Radinsky R, Dong Z, Fan D (1994) Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Metastasis Rev 13(2):209-222
74. Hahn ME, Gianneschi NC (2011) Enzyme-directed assembly and manipulation of organic nanomaterials. Chem Commun (Camb) 47 (43):11814-11821
75. US FaDA (2011) FDA Briefing document Oncology Drug [sic] Advisory Committee Meeting. December 5, 2007. BLA STN 125085/91.018. Avastin (bevacizumab). In
76. Pollack A (2011) F.D.A. Revokes approval of avastin for use as breast cancer drug. New York Times 2011 18th November, Sect. B1
77. Haines IE, Gabor Miklos G (2011) Time to mandate data release and independent audits for all clinical trials. Med J Aust 195(10):575-577
78. Patocs A, Zhang L, Xu Y et al (2007) Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med 357 (25):2543-2551
79. Akino T, Hida K, Hida Y, et al (2009) Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors. Am J Pathol 175(6):2657-2667
80. Sumida T, Kitadai Y, Shinagawa K et al (2011) Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model. Int J Cancer 128 (9):2050-2062